Agilent, Integrated DNA Technologies to Co-Market qPCR Products

The deal with IDT fills a particular gap for Agilent in the area of qPCR probe detection technology, a company official said.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories